Switzerland startup funding in Q2 2016
European tech funding raised by Switzerland startups during Q2 2016.
In Q2 2016, 26 startups in Switzerland closed 26 funding rounds and raised €190M in equity funding (excluding debt and grants), up 104.7% versus Q2 2015. Healthtech was the most active sector, and Polytech Ecosystem Venture was the most active investor. Data as of 20 Nov 2026.
Equity funding
€190M
+104.7% vs Q2 2015 · excl. debt & grants
Funding rounds
26
+73.3% vs Q2 2015
Companies
26
Top sector
Healthtech
Rank in Europe
#7
4.3% of European funding
Top-10 round share
87.9%
of disclosed capital
Funding by month
€ raised vs rounds, by monthSwitzerland — funding by month, Q2 2016 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Apr | €49M | 7 |
| May | €79M | 8 |
| Jun | €61M | 11 |
Top sectors
by € raisedSwitzerland — top sectors by capital, Q2 2016 — interactive chart.
Data table
| Switzerland — top sectors by capital, Q2 2016 | |
|---|---|
| Healthtech | €123M |
| Software | €47M |
| Hardware | €20M |
| Transportation | €8.2M |
| Fintech | €5.6M |
| Agritech | €3.0M |
| Energy | €2.7M |
| Cleantech | €2.7M |
Stage mix
by € raisedSwitzerland — stage mix, Q2 2016 — interactive chart.
Data table
| Switzerland — stage mix, Q2 2016 | |
|---|---|
| Series D+ | €75M |
| Series A | €35M |
| Series B | €35M |
| Series C | €21M |
| Early VC | €15M |
| Seed | €9.1M |
Top deals
largest disclosed rounds in Q2 2016| Company | Stage | Date | Amount |
|---|---|---|---|
| AC Immune | Series D+ | May 2016 | €40M |
| Nexthink | Series D+ | Apr 2016 | €35M |
| CRISPR Therapeutics | Series B | Jun 2016 | €35M |
| Aleva Neurotherapeutics | Series C | May 2016 | €16M |
| Nouscom | Series A | May 2016 | €12M |
| Biovotion | Series A | Jun 2016 | €9.0M |
| WayRay | Early VC | Jun 2016 | €8.2M |
| Anergis | Series C | Apr 2016 | €4.6M |
| Beekeeper | Early VC | Apr 2016 | €4.4M |
| Gamaya | Series A | May 2016 | €3.0M |
| Polyneuron Pharmaceuticals | Seed | May 2016 | €2.7M |
| DEPSys | Series A | Jun 2016 | €2.7M |
| beqom | Early VC | Apr 2016 | €2.6M |
| Relief Therapeutics | Series A | May 2016 | €2.5M |
| GenView | Series A | Jun 2016 | €2.0M |
Top investors
most active in Q2 2016, by deal count- Polytech Ecosystem Venture2 deals
- ZKB - Zurcher Kantonalbank2 deals
- Banexi Ventures1 deals
- Berner Kantonalbank - BEKB | BCBE1 deals
- btov Partners1 deals
- Clough Capital Partners1 deals
- EuroStars1 deals
- EVA Basel1 deals
- Franklin Templeton Investments1 deals
- Fyrfly Venture Partners1 deals